These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19492468)

  • 21. Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenomics J; 2009 Oct; 9(5):327-32. PubMed ID: 19652664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein variations for different chronic somatic disorders.
    Lund Håheim L; Nafstad P; Olsen I; Schwarze P; Rønningen KS
    Scand J Public Health; 2009 Aug; 37(6):640-6. PubMed ID: 19372230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein in ischaemic cardiomyopathy: assessing vascular risk in heart failure.
    Dickstein K
    Eur Heart J; 2005 Nov; 26(21):2218-9. PubMed ID: 16195321
    [No Abstract]   [Full Text] [Related]  

  • 24. C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study.
    Andersson J; Johansson L; Ladenvall P; Wiklund PG; Stegmayr B; Jern C; Boman K
    Cerebrovasc Dis; 2009; 27(6):544-51. PubMed ID: 19390179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal and fetal C-reactive protein genotype and first trimester CRP concentrations in maternal plasma.
    Hackney DN; Dunigan JT; Simhan HN
    J Reprod Immunol; 2008 Oct; 79(1):44-9. PubMed ID: 18805592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Life course weight gain and C-reactive protein levels in young adults: findings from a Brazilian birth cohort.
    Nazmi A; Gonzalez DC; Oliveira IO; Horta BL; Gigante DP; Victora CG
    Am J Hum Biol; 2009; 21(2):192-9. PubMed ID: 19107921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein: vascular risk marker in elderly patients with mental illness.
    Nilsson K; Gustafson L; Hultberg B
    Dement Geriatr Cogn Disord; 2008; 26(3):251-6. PubMed ID: 18841009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atherosclerosis as a systemic disease].
    Lahoz C; Mostaza JM
    Rev Esp Cardiol; 2007 Feb; 60(2):184-95. PubMed ID: 17338883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commentary: Social class, C-reactive protein and coronary heart disease.
    Casas JP
    Int J Epidemiol; 2008 Apr; 37(2):299-300. PubMed ID: 18285367
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrent miscarriage is associated with a family history of ischaemic heart disease: a retrospective cohort study.
    Smith GC; Wood AM; Pell JP; Hattie J
    BJOG; 2011 Apr; 118(5):557-63. PubMed ID: 21244619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients.
    Vivona N; Bivona G; Noto D; Sasso BL; Cefalù AB; Chiarello G; Falletta A; Ciaccio M; Averna MR
    Clin Biochem; 2009 Nov; 42(16-17):1713-8. PubMed ID: 19732763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetics in ischaemic heart disease].
    Wojtczak A; Skretkowicz J
    Pol Merkur Lekarski; 2007 Jul; 23(133):5-8. PubMed ID: 18051822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-environment interaction in the determination of levels of plasma fibrinogen.
    Humphries SE; Luong LA; Montgomery HE; Day IN; Mohamed-Ali V; Yudkin JS
    Thromb Haemost; 1999 Aug; 82(2):818-25. PubMed ID: 10605788
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of C-reactive protein in cerebrovascular disease: a critical review.
    Di Napoli M; Elkind MS; Godoy DA; Singh P; Papa F; Popa-Wagner A
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1565-84. PubMed ID: 22103876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CRP--a marker of a pro-inflammatory state and cardiovascular risk].
    Poledne R; Valenta Z; Pit'ha J
    Vnitr Lek; 2007 Apr; 53(4):391-5. PubMed ID: 17578172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetically determined reduction in antioxidative protection and increased risk of ischemic heart disease--secondary publication].
    Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen HH; Jensen GB; Nordestgaard BG
    Ugeskr Laeger; 2005 Feb; 167(7):767-70. PubMed ID: 15779264
    [No Abstract]   [Full Text] [Related]  

  • 39. C reactive protein and acute phase of ischaemic stroke.
    Di Napoli M
    BMJ; 2001 Jun; 322(7302):1605-6. PubMed ID: 11458909
    [No Abstract]   [Full Text] [Related]  

  • 40. C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies.
    Heikkilä K; Silander K; Salomaa V; Jousilahti P; Koskinen S; Pukkala E; Perola M
    Eur J Cancer; 2011 Feb; 47(3):404-12. PubMed ID: 20727736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.